Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−2.26USD
−95.73 MUSD
0.00USD
27.28 M
About Mind Medicine (MindMed) Inc.
Sector
CEO
Robert Barrow
Headquarters
New York
Website
Founded
2010
FIGI
BBG00F13HYQ7
Mind Medicine (MindMed), Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2010 and is headquartered in New York, NY.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of MNMD is 6.34 USD — it has decreased by −1.71% in the past 24 hours. Watch Mind Medicine (MindMed) Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Mind Medicine (MindMed) Inc. stocks are traded under the ticker MNMD.
MNMD stock has risen by 2.09% compared to the previous week, the month change is a 8.93% rise, over the last year Mind Medicine (MindMed) Inc. has showed a 146.69% increase.
We've gathered analysts' opinions on Mind Medicine (MindMed) Inc. future price: according to them, MNMD price has a max estimate of 55.00 USD and a min estimate of 14.00 USD. Watch MNMD chart and read a more detailed Mind Medicine (MindMed) Inc. stock forecast: see what analysts think of Mind Medicine (MindMed) Inc. and suggest that you do with its stocks.
MNMD reached its all-time high on Mar 20, 2017 with the price of 154.80 USD, and its all-time low was 0.01 USD and was reached on Dec 26, 2019. View more price dynamics on MNMD chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
MNMD stock is 4.66% volatile and has beta coefficient of 0.71. Track Mind Medicine (MindMed) Inc. stock price on the chart and check out the list of the most volatile stocks — is Mind Medicine (MindMed) Inc. there?
Today Mind Medicine (MindMed) Inc. has the market capitalization of 181.65 M, it has increased by 13.77% over the last week.
Yes, you can track Mind Medicine (MindMed) Inc. financials in yearly and quarterly reports right on TradingView.
Mind Medicine (MindMed) Inc. is going to release the next earnings report on Nov 7, 2024. Keep track of upcoming events with our Earnings Calendar.
MNMD earnings for the last quarter are −0.08 USD per share, whereas the estimation was −0.33 USD resulting in a 75.54% surprise. The estimated earnings for the next quarter are −0.28 USD per share. See more details about Mind Medicine (MindMed) Inc. earnings.
Mind Medicine (MindMed) Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
MNMD net income for the last quarter is −5.85 M USD, while the quarter before that showed −54.40 M USD of net income which accounts for 89.24% change. Track more Mind Medicine (MindMed) Inc. financial stats to get the full picture.
No, MNMD doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Oct 31, 2024, the company has 57.00 employees. See our rating of the largest employees — is Mind Medicine (MindMed) Inc. on this list?
Like other stocks, MNMD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Mind Medicine (MindMed) Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Mind Medicine (MindMed) Inc. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Mind Medicine (MindMed) Inc. stock shows the sell signal. See more of Mind Medicine (MindMed) Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.